Regulation of REGγ cellular distribution and function by SUMO modification

Cell Research

Volumn 21, Issue 5, 2011, Pages 807-816

  Wu, Yan ^a   Wang, Lu ^a   Zhou, Ping ^a   Wang, Guangqiang ^a   Zeng, Yu ^a   Wang, Ying ^a   Liu, Jian ^a,c   Zhang, Bianhong ^a   Liu, Shuang ^a   Luo, Honglin ^b   Li, Xiaotao ^a,c  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

modification; PIAS1; REG ; SUMO

Indexed keywords

AMINO ACID; AUTOANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI ANTIGEN; MUTANT PROTEIN; PIAS1 PROTEIN, HUMAN; PROTEASOME; PROTEIN INHIBITOR OF ACTIVATED STAT; SUMO PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CYTOPLASM; HUMAN; METABOLISM; MOUSE; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; SUMOYLATION;

AMINO ACIDS; ANIMALS; AUTOANTIGENS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASM; HUMANS; MICE; MUTANT PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STABILITY; PROTEIN TRANSPORT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION;

EID: 79955631101     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2011.57     Document Type: Article

References (24)

1. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin- independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007; 26:843-852. (Pubitemid 46921008)
2. Li X, Amazit L, Long W, Lonard DM, Monaco JJ, O'Malley BW. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007; 26:831-842. (Pubitemid 46921009)
3. Li X, Lonard D, Jung S, et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin-and ATP-independent manner by the REG [gamma] proteasome. Cell 2006; 124:381-392. (Pubitemid 43121985)
4. Mao I, Liu J, Li X, Luo H. REGgamma, a proteasome activator and beyond? Cell Mol Life Sci 2008; 65:3971-3980.
5. Roessler M, Rollinger W, Mantovani-Endl L, et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006; 5:2092.
6. Yu G, Zhao Y, He J et al. Comparative analysis of REG{gamma} expression in mouse and human tissues. J Mol Cell Biol 2010; 2:192-198.
7. Yeh ET. SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 2009; 284:8223-8227.
8. Wang Y, Dasso M. SUMOylation and deSUMOylation at a glance. J Cell Sci 2009; 122:4249.
9. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8:947-956. (Pubitemid 350176509)
10. Yurchenko V, Xue Z, Sadofsky M. SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol Cell Biol 2006; 26:1786.
11. Matunis MJ, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPaseactivating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 1996; 135:1457-1470. (Pubitemid 26427644)
12. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2:233-239. (Pubitemid 128373648)
13. Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J 2008; 27:852-864. (Pubitemid 351417171)
14. Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 2005; 15:27-33. (Pubitemid 40094678)
15. Miyauchi Y, Yogosawa S, Honda R, Nishida T, Yasuda H. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J Biol Chem 2002; 277:50131-50136. (Pubitemid 36014466)
16. Tan JA, Song J, Chen Y, Durrin LK. Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1. Mol Cell Biol 2010; 30:2823-2836.
17. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009; 462:935-939.
18. Kahyo T, Nishida T, Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 2001; 8:713-718. (Pubitemid 32946947)
19. Lin D, Huang Y, Jeng J, et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of SUMOylated transcription factors. Mol Cell 2006; 24:341-354. (Pubitemid 44647910)
20. Figueroa-Romero C, Iniguez-Lluhi JA, Stadler J, et al. SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J 2009; 23:3917-3927.
21. Wood LD, Irvin BJ, Nucifora G, Luce KS, Hiebert SW. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc Natl Acad Sci USA 2003; 100:3257-3262. (Pubitemid 36356570)
22. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007; 131:584-595. (Pubitemid 350007694)
23. Liang M, Melchior F, Feng X, Lin X. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. J Biol Chem 2004; 279:22857-22865. (Pubitemid 38685586)
24. Verger A, Perdomo J, Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep 2003; 4:137-142. (Pubitemid 36322153)